Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025)

Eton Pharmaceuticals has disclosed Capital Expenditures across 7 years of filings, most recently posting $49000.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $49000.0, up 308.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $333000.0 (up 1180.77% YoY), and the FY2025 annual result was $333000.0, up 1180.77% from the prior year.
• Capital Expenditures came in at $49000.0 for Q4 2025 at Eton Pharmaceuticals, down from $284000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $284000.0 in Q3 2025 to a low of $2000.0 in Q3 2021.
• The 4-year median for Capital Expenditures is $12000.0 (2022), against an average of $44777.8.
• Across the five-year window, Capital Expenditures tumbled 90.91% in 2021 and jumped 308.33% in 2025, its largest moves.
• Eton Pharmaceuticals' Capital Expenditures stood at $4000.0 in 2021, then soared by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then jumped by 308.33% to $49000.0 in 2025.
• The last three Capital Expenditures figures came in at $49000.0 (Q4 2025), $284000.0 (Q3 2025), and $12000.0 (Q4 2024), per Business Quant data.